Funding for this research was provided by:
King's College London
Text and Data Mining valid from 2018-02-08
Received: 17 January 2017
Accepted: 21 December 2017
First Online: 8 February 2018
Duality of interest
: SAA has served on advisory boards or teaching panels for Medtronic, Novo Nordisk and Roche. PC has served on advisory boards and received speaker fees from Medtronic, Roche, Novo Nordisk, AstraZeneca, Lilly, Abbott Diabetes and Sanofi, Ascenscia Ltd.